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Control of Human Brucellosis 
 Addressing in domestic livestock most 
economical approach    
 - in 1 study benefit:cost ratio of 3.2 for 
vaccination (Roth et al 2004) 
 Pasturization of milk products 
 
Basic Principles 
 Increase Herd Immunity 
 Identify/Characterize Infection 
 Reduce Infection/Prevent Spread or 
Transmission 
 Reduce Risk 
 Improve Available Tools/Techniques 
Brucella spp.:Host 
Relationships 
 B. melitensis:  cattle, camels 
 B. suis:   not known in Africa 
 B. abortus  cattle, camels 
 
Large Animal Brucellosis 
Vaccines 
 B. melitensis:  None approved 
 B. suis:   none approved; B. suis  
     strain 2 (China) 
 B. abortus  strains 19 (108-109 CFU;  
     1010 CFU,  
   RB51 (1010 CFU), &  
  82 (109-1010 CFU) 
 
Protective Immunity against 
Brucella: Primarily Cell-mediated 
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Thoughts on Brucellosis 
Vaccines 
 Vaccination alone will not eradicate brucellosis 
 Vaccines are very good at reducing transmission 
and clinical disease; very poor at preventing 
seroconversion after exposure 
 Long-term protection related to cell-mediated 
immunity 
 Antibodies relatively unimportant for efficacy 
 Many vaccine strains can be pathogenic in humans 
or pregnant animals 
Factors Affecting Effectiveness of a 
Vaccination Program 
 Efficacy of Vaccine in Targeted Species
 Delivery Method 
 Percentage of population vaccinated 
 Duration of Immunity 
 Cost 
 
Lipopolysaccharide structure 
of virulent and vaccine strains 
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The O-side chain is the immunodominant antigen 
 of Brucella for antibody responses 
Tools that May Be Useful 
 Break country down into smaller areas 
 Reward Herds/Areas for controlling 
disease 
 Concentrate Resources in Areas of 
Greatest Infection or Human 
Transmission 
 Risk Management 
 Public Education 
